Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines
Natural products that inhibit the proteasome have been fruitful starting points for the development of drug candidates. Those of the syringolin family have been underexploited in this context. Using the published model for substrate mimicry by the syringolins and knowledge about the substrate prefer...
Main Authors: | Totaro, Kyle A., Barthelme, Dominik, Simpson, Peter T., Sello, Jason K., Sauer, Robert T. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2017
|
Online Access: | http://hdl.handle.net/1721.1/111148 https://orcid.org/0000-0002-1719-5399 |
Similar Items
-
Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium Tuberculosis Proteasome
by: Totaro, Kyle A., et al.
Published: (2018) -
Identification of the Cdc48•20S Proteasome as an Ancient AAA+ Proteolytic Machine
by: Barthelme, Dominik, et al.
Published: (2014) -
Proteasome activity imaging and profiling characterizes bacterial effector syringolin A.
by: Kolodziejek, I, et al.
Published: (2011) -
Pseudomonas syringae pv. syringae uses proteasome inhibitor syringolin A to colonize from wound infection sites.
by: Misas-Villamil, J, et al.
Published: (2013) -
Architecture and assembly of the archaeal Cdc48*20S proteasome
by: Barthelme, Dominik, et al.
Published: (2014)